首頁 > 市場調查報告書 > 醫療設備

醫學影像診斷核子醫學

市場調查報告書

商品編碼

2148412

放射性藥物市場：按類型、放射性同位素、應用、最終用戶和地區分類

Radiopharmaceuticals Market, By Type, By Radioisotope, By Application, By End User, By Geography

出版日期: 2026年09月25日 | 出版商:

Coherent Market Insights | 英文 250 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

預計到 2026 年，放射性藥物市場規模將達到 91.5 億美元，到 2033 年將達到 198.427 億美元。預計從 2026 年到 2033 年，該市場將以 11.7% 的複合年成長率成長。

報告範圍		報告詳情
基準年：	2025	2026年市場規模：	91.5億美元
歷史數據時期：	2020年至2024年	預測期：	2026年至2033年
2026年至2033年預測期間的複合年成長率：	11.70%	2033年市場規模預測：	198.427億美元

放射性藥物是由放射性同位素與藥物載體結合而成的特殊藥物，用於診斷成像和標靶治療。它們能選擇性地在特定組織、器官或細胞受體中積聚，從而實現生理過程的可視化，尤其是在腫瘤學領域，可將輻射直接輸送至病變細胞。此市場涵蓋用於PET和SPECT成像的診斷試劑，以及用於標靶放射性核素治療的治療試劑。

由於癌症、心血管疾病和神經系統疾病的發生率不斷上升，以及核醫基礎設施、同位素生產和分子標靶技術的進步，全球放射性藥物市場正在成長。隨著標靶治療療法的日益普及，放射性藥物的應用範圍已從傳統的診斷用途擴展到更廣泛的領域，但對生產、處理、分銷和給藥的嚴格要求仍然是這一高度專業化市場的顯著特徵。

市場動態

全球放射性藥物市場成長的主要促進因素包括癌症和其他慢性疾病負擔的加重、靶向放射性核素療法的廣泛應用，以及正子斷層掃描（PET）和單光子發射電腦斷層掃描（SPECT）技術的日益普及。此外，新興市場對核醫基礎設施、同位素生產和新一代放射性藥物的投資增加，也促進了市場成長。

然而，放射性藥物市場的成長受到許多因素的限制，例如同位素半衰期短、供應鏈複雜、監管要求嚴格、生產成本高以及熟練人才短缺。儘管如此，「診療整合」（治療診斷學）領域仍蘊藏著巨大的機遇，該領域將診斷影像與使用分子匹配放射性藥物的標靶治療相結合。錒-225等α發射放射性同位素的進步、治療產品線的擴展、更廣泛的臨床適應症以及製藥公司、生物技術公司和研究機構之間合作的加強，預計將為市場的新成長鋪平道路。

本次調查的主要特點

本研究揭示了各個細分市場的潛在商機，並為該市場說明了一個具有吸引力的投資提案矩陣。
此外，本研究還深入分析了市場促進因素、限制因素、機會、新產品發布和批准、市場趨勢、區域展望以及領先企業採取的競爭策略。
本研究根據以下參數介紹了全球放射性藥物市場主要參與者的概況：公司概況、產品系列、主要亮點、財務績效和策略。
本報告提供的見解將使企業行銷負責人和經營團隊能夠就未來的產品發布、產品類型升級、市場擴張和行銷策略做出明智的決策。
這份全球放射性藥物市場報告旨在為行業內的各種相關人員提供參考，包括投資者、供應商、產品製造商、經銷商、新參與企業和金融分析師。
相關人員可以透過利用全球放射性藥物市場分析中使用的各種策略矩陣來簡化決策過程。

北美洲
- 美國
- 加拿大
拉丁美洲
- 巴西
- 阿根廷
- 墨西哥
- 其他拉丁美洲國家
歐洲
- 德國
- 英國
- 西班牙
- 法國
- 義大利
- 俄羅斯
- 其他歐洲國家
亞太地區
- 中國
- 印度
- 日本
- 澳洲
- 韓國
- ASEAN
- 其他亞太國家
中東
- 海灣合作理事會國家
- 以色列
- 其他中東國家
非洲
- 南非
- 北非
- 中非

第9章競爭情勢

Novartis AG
GE HealthCare Technologies Inc.
Cardinal Health, Inc.
Curium Pharma
Lantheus Holdings, Inc.
Bayer AG
Bracco Imaging SpA
Siemens Healthineers AG
Jubilant Pharmova Limited
Telix Pharmaceuticals Limited

第10章分析師建議

機會分析
分析師意見
Coherent Opportunity Map

第11章參考文獻與調查方法

參考
調查方法
關於本公司

簡介目錄

Product Code: CMI10157

Radiopharmaceuticals Market is estimated to be valued at USD 9,150.0 Mn in 2026 and is expected to reach USD 19,842.7 Mn by 2033, growing at a compound annual growth rate (CAGR) of 11.7% from 2026 to 2033.

Report Coverage		Report Details
Base Year:	2025	Market Size in 2026:	USD 9,150.0 Mn
Historical Data for:	2020 To 2024	Forecast Period:	2026 To 2033
Forecast Period 2026 to 2033 CAGR:	11.70%	2033 Value Projection:	USD 19,842.7 Mn

Radiopharmaceuticals are special drugs made of radioactive isotopes bound to pharmaceutical vectors for diagnostic imaging and targeted therapy. They selectively gather in specific tissues, organs or cellular receptors to help in the visualization of physiological processes and the delivery of radiation directly to diseased cells, especially in oncology. The market encompasses diagnostic agents used in PET and SPECT imaging and therapeutic agents used in targeted radionuclide therapy.

The global radiopharmaceuticals market is growing due to the rising prevalence of cancer, cardiovascular and neurological disorders, coupled with advances in nuclear medicine infrastructure, isotope production and molecular targeting. The growing adoption of targeted treatments is expanding radiopharmaceuticals beyond traditional diagnostic uses while strict requirements for manufacturing, handling, distribution and administration continue to define this highly specialized market.

Market Dynamics

The global radiopharmaceuticals market is driven by the rise in burden of cancer and other chronic diseases, increasing use of targeted radionuclide therapies and growing applications of positron emission tomography (PET) and single-photon emission computer tomography (SPECT). Rising investments in infrastructure development for nuclear medicine, isotope production and next-generation radiopharmaceuticals especially in emerging markets are other factors contributing to the market growth.

However, the growth of Radiopharmaceuticals market is limited by factors such as short half-life of isotopes, complex supply chains, stringent regulatory requirements, high manufacturing costs and lack of specialized professionals. Nevertheless, significant opportunities exist in theranostics, which combines diagnostic imaging with targeted treatment using molecularly matched radiopharmaceuticals. Advances in alpha-emitting radioisotopes such as Actinium-225, expanding therapeutic pipelines, broader clinical indications, and increasing collaborations among pharmaceutical companies, biotechnology firms, and research institutions are expected to create new avenues for market growth

Key Features of the Study

It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global radiopharmaceuticals market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
Key companies covered as a part of this study include Novartis AG, GE HealthCare Technologies Inc., Cardinal Health, Inc., Curium Pharma, Lantheus Holdings, Inc., Bayer AG, Bracco Imaging S.p.A., Siemens Healthineers AG, Jubilant Pharmova Limited, and Telix Pharmaceuticals Limited
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
The global radiopharmaceuticals market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global radiopharmaceuticals market

Market Segmentation

Type Insights (Revenue, USD Mn, 2021 - 2033)
- Diagnostic Radiopharmaceuticals
- Therapeutic Radiopharmaceuticals
Radioisotope Insights (Revenue, USD Mn, 2021 - 2033)
- Technetium-99m
- Fluorine-18
- Gallium-68
- Lutetium-177
- Iodine-131
- Actinium-225
- Others
Application Technique Insights (Revenue, USD Mn, 2021 - 2033)
- Oncology
- Cardiology
- Neurology
- Others
End User Insights (Revenue, USD Mn, 2021 - 2033)
- Hospitals and Clinics
- Diagnostic Imaging Centers
- Nuclear Medicine Centers
- Academic and Research Institutes
- Others
Regional Insights (Revenue, USD Mn, 2021 - 2033)
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- South Africa
- North Africa
- Central Africa
Key Players Insights
- Novartis AG
- GE HealthCare Technologies Inc.
- Cardinal Health, Inc.
- Curium Pharma
- Lantheus Holdings, Inc.
- Bayer AG
- Bracco Imaging S.p.A.
- Siemens Healthineers AG
- Jubilant Pharmova Limited
- Telix Pharmaceuticals Limited

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Global Radiopharmaceuticals Market, By Type
- Global Radiopharmaceuticals Market, By Radioisotope
- Global Radiopharmaceuticals Market, By Application
- Global Radiopharmaceuticals Market, By End User
- Global Radiopharmaceuticals Market, By Region

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
Impact Analysis
Key Highlights
Regulatory Scenario
Product Launches/Approvals
PEST Analysis
PORTER's Analysis
Market Opportunities
Industry Trends

4. Global Radiopharmaceuticals Market, By Type, 2021-2033, (USD Mn)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
Diagnostic Radiopharmaceuticals
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
Therapeutic Radiopharmaceuticals
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)

5. Global Radiopharmaceuticals Market, By Radioisotope, 2021-2033, (USD Mn)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
Technetium-99m
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
Fluorine-18
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
Gallium-68
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
Lutetium-177
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
Iodine-131
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
Actinium-225
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)

6. Global Radiopharmaceuticals Market, By Application, 2021-2033, (USD Mn)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
Oncology
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
Cardiology
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
Neurology
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)

7. Global Radiopharmaceuticals Market, By End User, 2021-2033, (USD Mn)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
Hospitals and Clinics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
Diagnostic Imaging Centers
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
Nuclear Medicine Centers
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
Academic and Research Institutes
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)

8. Global Radiopharmaceuticals Market, By Region, 2021 - 2033, Value (USD Mn)

Introduction
- Market Share (%) Analysis, 2026, 2029 & 2033, Value (USD Mn)
- Market Y-o-Y Growth Analysis (%), 2022 - 2033, Value (USD Mn)
- Regional Trends
North America
- Introduction
- Market Size and Forecast, By Type, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Radioisotope, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By End User,2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Mn)
  - U.S.
  - Canada
Latin America
- Introduction
- Market Size and Forecast, By Type, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Radioisotope, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By End User,2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Mn)
  - Brazil
  - Argentina
  - Mexico
  - Rest of Latin America
Europe
- Introduction
- Market Size and Forecast, By Type, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Radioisotope, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By End User,2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Mn)
  - Germany
  - U.K.
  - Spain
  - France
  - Italy
  - Russia
  - Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, By Type, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Radioisotope, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By End User,2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Mn)
  - China
  - India
  - Japan
  - Australia
  - South Korea
  - ASEAN
  - Rest of Asia Pacific
Middle East
- Introduction
- Market Size and Forecast, By Type, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Radioisotope, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By End User,2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Mn)
  - GCC Countries
  - Israel
  - Rest of Middle East
Africa
- Introduction
- Market Size and Forecast, By Type, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Radioisotope, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By End User,2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Country/Region, 2021 - 2033, Value (USD Mn)
  - South Africa
  - North Africa
  - Central Africa

9. Competitive Landscape

Novartis AG
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
GE HealthCare Technologies Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Cardinal Health, Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Curium Pharma
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Lantheus Holdings, Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Bayer AG
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Bracco Imaging S.p.A.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Siemens Healthineers AG
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Jubilant Pharmova Limited
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Telix Pharmaceuticals Limited
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies